The Third Wave

  • Author: Vários
  • Narrator: Vários
  • Publisher: Podcast
  • Duration: 393:21:12
  • More information

Informações:

Synopsis

The Third Wave podcast takes a fresh look at the world of psychedelics, hearing the stories of people both in the psychedelic fringe and in mainstream society. We want to share how psychedelics are transforming the lives of people everywhere, both inside and outside of the psychedelic community.By revealing and unraveling the vast range of personal psychedelic experiences, we hope to change the cultural stigma surrounding psychedelic use. Our conversations will focus on the use of psychedelics within two main frameworks: as tools for creativity and as medicine for mental health issues.

Episodes

  • Microdosing Ibogaine for Parkinsons: What One Case Study Found - Tobias Erny

    Microdosing Ibogaine for Parkinson's: What One Case Study Found - Tobias Erny

    02/11/2026 Duration: 58min

    Paul F. Austin and Tobias Erny explore low-dose ibogaine for Parkinson's disease: a published case report, GDNF, who responds, and drug safety. Find full show notes and links here: https://thethirdwave.co/podcast/episode-378/?ref=250 In this episode of The Psychedelic Podcast, Paul F. Austin welcomes Tobias Erny, a Swiss iboga practitioner, researcher, and Co-Director of the Global Iboga Therapy Alliance. Tobias shares how ibogaine helped him end his own opiate addiction, and how that recovery grew into two decades of work with iboga, including a published case report on low-dose ibogaine for Parkinson's disease. Paul and Tobias explore why ibogaine may help some people living with Parkinson's, from GDNF, a growth factor that supports dopamine neurons, to its effects on mood and motivation. They also discuss how ibogaine differs from the whole iboga plant, why many patients don't respond, the medication interactions families should understand first, and why starting low and staying honest about uncertainty ma

  • Daily Low-Dose Ketamine: Why Repetition May Matter More Than Intensity - Eiad Asbahi

    Daily Low-Dose Ketamine: Why Repetition May Matter More Than Intensity - Eiad Asbahi

    20/10/2026 Duration: 38min

    In this episode of The Psychedelic Podcast, Paul F. Austin sits down with Eiad Asbahi, founder of Mindscape, a patient care coordination platform that connects people with licensed providers and pharmacies for low-dose ketamine care. Eiad spent 17 years running a hedge fund and reached the kind of success he had always dreamed about. Then his largest investment collapsed and his marriage ended, and he was forced to look inward. This epsiode is sponsored by Eiad Asbahi. Eiad describes the moment he realized he was the common denominator in his own failures. He talks about the core belief underneath it all, that he was "defective," and how Internal Family Systems therapy showed him there are no bad parts. He explains how building inner safety changed the way he parents his daughter, and why he uses ketamine to reconnect rather than to escape. Paul and Eiad also discuss the thinking behind Mindscape's daily low-dose model and the case for repetition over peak experiences. The conversation ends with a candid disa

  • Rectal 5-MeO-DMT: A Novel Path Through Pelvic Trauma - Mira Funk, LCSW

    Rectal 5-MeO-DMT: A Novel Path Through Pelvic Trauma - Mira Funk, LCSW

    05/10/2026 Duration: 01h06min

    In this episode of The Psychedelic Podcast, Paul F. Austin sits down with Mira Funk, LCSW, a Harvard-educated psychotherapist and the founder of Unjourneying, a private practice built around 5-MeO-DMT, N,N-DMT, and salvia divinorum. This episode is sponsored by Mira Funk. Mira traces her path from fourteen years of Zen meditation into psychedelic work, and explains how a severe reaction to a common nootropic supplement unexpectedly reoriented her entire practice toward presence rather than dramatic, otherworldly trips. She and Paul go deep on the extended-release routes she has pioneered, including subcutaneous, rectal, and vaginal 5-MeO-DMT, and the titrated e-mesh method she uses for salvia divinorum. Throughout the conversation, Mira is candid about the real risks of self-administration, the role of chronic illness in shaping her gentle approach, and why she believes structure matters most for those newest to this work. Mira Funk, LCSW (she/her), is a Harvard-educated queer, nonbinary psychotherapist and p

  • Building a Real Psychedelic Renaissance - Dave Asprey

    Building a Real Psychedelic Renaissance - Dave Asprey

    25/09/2026 Duration: 29min

    Paul talks with biohacking pioneer Dave Asprey about medicalization, microdosing, consciousness, and Dave's new BEYOND Wonderland psychedelics conference in Austin. In this bonus episode, Paul welcomes back Dave Asprey, founder of Bulletproof Coffee and creator of the biohacking movement, to talk about BEYOND Wonderland, the psychedelics conference Dave has revamped for October 12-14 in Austin. They also get into medicalization, the CIA's documented role in psychedelic history, what responsible microdosing regulation could look like, and why Dave is as focused on unlocking latent human ability as he is on fixing what's broken. Want to attend BEYOND Wonderland? Get 10% off your ticket with code THIRDWAVE at wonderlandconference.com (Code expires October 10). Episode links: BEYOND Wonderland – Use code THIRDWAVE for 10% off: https://wonderlandconference.com/ Dave Asprey's website: https://daveasprey.com/  Third Wave occasionally partners with or shares information about other people, companies, and/or provide

  • Psychedelics, AI, and the Right to Think - Ramez Naam

    Psychedelics, AI, and the Right to Think - Ramez Naam

    23/09/2026 Duration: 01h10min

    In this episode of The Psychedelic Podcast, Paul F. Austin speaks with computer scientist, climate investor, and Nexus author Ramez Naam about psychedelics, AI, neurotechnology, and cognitive liberty. Find full show notes and links here: https://thethirdwave.co/podcast/episode-374/?ref=278 Ramez shares how psychedelic experiences sparked his interest in neuroscience, inspired his books, and helped redirect his work toward climate and clean energy. He and Paul explore what brain-computer interfaces can do today, the future of psychedelic mental healthcare, and how to protect freedom of thought as AI becomes a more personal tool. Ramez Naam is a computer scientist, mission-focused investor, climate activist, and award-winning author of science fiction and nonfiction. His Nexus trilogy explores the possibilities of mind-to-mind communication technology, while his nonfiction examines human augmentation, neuroscience, climate, and clean energy. He serves as Co-Chair for Energy and Environment at Singularity Univer

  • Psychedelic Therapy Needs More Than Good Intentions - Kylea Taylor, M.S., LMFT

    Psychedelic Therapy Needs More Than Good Intentions - Kylea Taylor, M.S., LMFT

    14/09/2026 Duration: 55min

    In this episode of The Psychedelic Podcast, Paul F. Austin speaks with therapist and InnerEthics® founder Kylea Taylor about why responsible psychedelic therapy requires more than good intentions. Find full show notes and links here: https://thethirdwave.co/podcast/episode-373/?ref=278 Kylea explains why non-ordinary states can amplify intimacy, vulnerability, countertransference, and practitioner blind spots. She presents ethics as an ongoing practice of self-inquiry, restraint, and right relationship rather than a set of rules consulted only after something goes wrong. Paul and Kylea also examine personal experience as preparation for facilitation, the complexities of touch and consent, the meaning of inner healing intelligence, and why compassionate peer consultation is essential for anyone holding space in psychedelic work. Kylea Taylor, M.S., LMFT, is a California licensed therapist and the founder of InnerEthics®, a self-reflective approach to relational ethics taught in breathwork and psychedelic pract

  • Iboga Initiation and the Wisdom of Discomfort - Paije Alexandra West

    Iboga Initiation and the Wisdom of Discomfort - Paije Alexandra West

    07/09/2026 Duration: 01h03min

    In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Paije Alexandra West, founder of ETÉREO, about iboga, ibogaine, and Bwiti initiation. Drawing on Paul's recent retreat experience at ETÉREO in Baja, they examine what can be lost when iboga is reduced to a clinical alkaloid and how traditional ceremony can coexist with rigorous medical screening. Paije explains the differences between iboga root bark and total alkaloid extract, the role of Bwiti music, and why discomfort, community, and long-term integration are central to working responsibly with this demanding medicine. Paije Alexandra West is the founder and lead iboga provider at ETÉREO | Center for Truth, an iboga retreat center outside Todos Santos, Baja California Sur. A twice-initiated Bwiti practitioner, she began on the clinical side, supporting guests through detox and aftercare at ibogaine clinics. Her commitment deepened after losing her brother to a fentanyl overdose. Paije trained in Gabon with the Missoko Bwiti, completed

  • SSRI Tapering and Psychedelic Readiness - Dr. Josef Witt-Doerring

    SSRI Tapering and Psychedelic Readiness - Dr. Josef Witt-Doerring

    31/08/2026 Duration: 59min

    In this episode of The Psychedelic Podcast, Paul F. Austin speaks with psychiatrist and TaperClinic founder Dr. Josef Witt-Doerring about antidepressant withdrawal, psychiatric deprescribing, and psychedelic readiness. Find full show notes and links here: https://thethirdwave.co/podcast/episode-371/?ref=278 Josef explains what he learned reviewing drug safety at the FDA, why withdrawal can be mistaken for relapse, and how tapering often becomes more difficult at lower doses. They also explore the lifestyle foundations of mental health, benzodiazepine withdrawal, and why psychedelic clinics may need far more sophisticated support as increasingly medicated patients seek psilocybin, MDMA, LSD, and ketamine. Dr. Josef Witt-Doerring, MD, is a psychiatrist renowned for his expertise in drug tapering and withdrawal management. With years of experience in clinical psychiatry, he has developed a particular interest and specialization in assisting patients with the safe and effective tapering of psychiatric medications

  • SSRIs, Psychedelics,  Rethinking Mental Health Treatment - Robert Whitaker

    SSRIs, Psychedelics, & Rethinking Mental Health Treatment - Robert Whitaker

    24/08/2026 Duration: 01h08min

    In this episode of The Psychedelic Podcast, Paul F. Austin speaks with investigative journalist Robert Whitaker about the evidence behind psychiatric prescribing, SSRI withdrawal, and what psychedelic medicine can learn from that history. Find full show notes and links here: https://thethirdwave.co/podcast/episode-370/?ref=278 Whitaker revisits the chemical imbalance theory, long-term antidepressant outcomes, and how psychiatric drugs evolved from short-term interventions toward chronic use. He also explores the social and environmental dimensions of mental health before turning to psychedelic medicine and the risks of recreating a drug-centered model of care. Robert Whitaker is the author of five books, three examining the history of psychiatry. His 2010 book, Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness, won the U.S. Investigative Reporters and Editors award for best investigative journalism. He is president of the Mad in America Foundation and founder

  • Ketamine, SSRIs  the Future of Psychedelic Therapy - Dr. Remi Drozd

    Ketamine, SSRIs & the Future of Psychedelic Therapy - Dr. Remi Drozd

    17/08/2026 Duration: 53min

    In this episode of The Psychedelic Podcast, Paul F. Austin welcomes Dr. Remi Drozd back to explore ketamine, SSRIs, and the changing landscape of psychedelic mental health care. Find full show notes and links here: https://thethirdwave.co/podcast/episode-369/?ref=278 Since Remi first appeared on the podcast in Episode 182, Lucid Therapeutics has grown from a small ketamine practice into a ten-room interventional mental health clinic offering ketamine treatments, Spravato, TMS, therapy, integration support, and other approaches. Paul and Remi examine one of the less-discussed challenges facing psychedelic medicine: many prospective patients are already taking antidepressants and other psychiatric medications. Remi explains why SSRI tapering needs to be individualized, how ketamine may support some patients through treatment transitions, and what clinicians may need to consider as psilocybin and other psychedelic therapies move closer to mainstream clinical use. Dr. Remi Drozd is a board-certified physician and

  • Psychedelic Medicines Biggest Blind Spots - Dr. Richard Louis Miller

    Psychedelic Medicine's Biggest Blind Spots - Dr. Richard Louis Miller

    10/08/2026 Duration: 48min

    In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Dr. Richard Louis Miller about what psychedelic medicine must get right as it moves toward broader acceptance. Richard explains why transparent reporting of adverse effects is essential to informed choice, where research still leaves important gaps, and how commercialization could shape access and treatment. They examine 5-MeO-DMT, group therapy, and the limits of one-to-one care. Richard also shares his approach to aging through exercise, real food, rest, and human connection. Dr. Richard Louis Miller is a clinical psychologist, author, and broadcaster with over 65 years of clinical experience in mind-body health. At 87, he continues to practice, teach, and share the tools that have helped thousands of people master anxiety, overthinking, and negative self-talk. He founded the Cokenders Alcohol and Drug Program, which detoxified over 1,500 people without medication, and created the Health Sanctuary at Wilbur Hot Springs, which he directed

  • Inside the World of Dark Retreats - Ian Gardner

    Inside the World of Dark Retreats - Ian Gardner

    04/08/2026 Duration: 54min

    In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Ian Gardner, founder and CEO of The Acraya, about dark retreats as an ancient contemplative practice now entering Western culture. This episode is sponsored by The Acraya. Listeners of The Psychedelic Podcast can receive 5% off an Acraya retreat. Visit https://acraya.global/thirdwave and use discount code 3WAVE when booking. Ian explains what happens when external stimulation disappears, why boredom and difficult inner material can become central parts of the experience, and how dark retreats compare with psychedelics and extended meditation. He also discusses screening, facilitator training, post-retreat integration, and his vision for technologically supported retreat centers in Costa Rica, Nepal, Bali, and beyond. Episode Highlights: Ancient roots of dark retreat practice What remains when sensory anchors disappear Psychedelics versus gradual inner awakening Boredom as a gateway to deeper material Preparing for several days in darkness

  • Healing the Need to Prove: Psychedelics and Enoughness - Blake Mycoskie

    Healing the Need to Prove: Psychedelics and Enoughness - Blake Mycoskie

    28/07/2026 Duration: 59min

    In this episode of The Psychedelic Podcast, Paul F. Austin welcomes TOMS founder Blake Mycoskie for an honest conversation about depression, psychedelics, recovery, and the lifelong need to prove his worth. Find full show notes and links here: https://thethirdwave.co/podcast/episode-366/?ref=278 Blake explains how an early ayahuasca experience gave him the sense that he had already done enough, even though he had not yet learned to feel that he was enough. He shares what followed after selling TOMS, including a profound depression, a psychiatric diagnosis he later came to question, four medications, and a carefully supported nine-month taper. Paul and Blake also discuss the daily meditation practice that helped reshape his relationship with self-worth, the return of his entrepreneurial energy, his $100 million commitment to psychedelic research and access, and why the future of psychedelic care will require scalable integration, group support, and careful use of emerging AI tools. Blake Mycoskie is the founde

  • Inside the God Molecule: An Honest Look at 5-MeO-DMT

    Inside the God Molecule: An Honest Look at 5-MeO-DMT

    22/07/2026 Duration: 27min

    In this solo episode, Paul F. Austin offers a candid introduction to 5-MeO-DMT, one of the shortest and most intense psychedelic experiences. Find full show notes and links here: https://thethirdwave.co/podcast/episode-365/?ref=278 Paul distinguishes synthetic 5-MeO-DMT from Bufo, compares it with N,N-DMT and psilocybin, and examines the risks that social media narratives often leave out. He also explores low-dose versus breakthrough work, nervous system readiness, medication interactions, facilitator screening, reactivations, ecological responsibility, and why integration may matter far more than the experience itself. Paul F. Austin is an entrepreneur, educator, and pioneer in the psychedelic field. He is the founder of Third Wave, a leading platform dedicated to psychedelic education, and the Psychedelic Coaching Institute, which trains coaches and practitioners to responsibly support psychedelic experiences and integration. As host of The Psychedelic Podcast, Paul has interviewed hundreds of researchers,

  • Posting About Psychedelics in the Age of AI - Victoria J. Cvitanovic

    Posting About Psychedelics in the Age of AI - Victoria J. Cvitanovic

    13/07/2026 Duration: 01h02min

    In this special replay of a past Psychedelic Coaching Institute webinar, Paul F. Austin is joined by Victoria J. Cvitanovic, attorney and leader of the Psychedelic Medicine and AI Governance practices at Rudick Law Group, for a practical conversation on how AI is reshaping psychedelic practice. Find full show notes and links here: https://thethirdwave.co/podcast/episode-364/?ref=278 Together, Paul and Victoria explore why psychedelic content can get flagged online, how automated moderation systems are changing what practitioners can safely post, and why educational content may still be misread by platforms like Meta. They also discuss payment processor risk, account freezes, client data privacy, AI note-taking tools, website compliance, and the legal nuance practitioners need to understand before building or growing their work online. Victoria J. Cvitanovic is a psychedelic medicine, cannabis, wellness, and tech attorney. In addition to her law degree, Victoria holds CIPP-US and AIGP certifications from the I

  • Why Psychedelic Therapy Needs to Be Relational - Steven C. Hayes, Ph.D.

    Why Psychedelic Therapy Needs to Be Relational - Steven C. Hayes, Ph.D.

    06/07/2026 Duration: 01h17min

    In this episode of The Psychedelic Podcast, Paul F. Austin welcomes Steven C. Hayes, Ph.D., originator of Acceptance and Commitment Therapy, creator of Relational Frame Theory, and one of the most cited psychologists in the world. Full Show Notes: https://thethirdwave.co/podcast/episode-363/?ref=278 Hayes reflects on his early experiences in the Summer of Love, why psychedelics were never meant to be treated as a party, and how those formative explorations helped shape his lifelong work on psychological flexibility. Paul and Steven explore what psychedelics can reveal about the nature of self, the role of preparation and context in safe outcomes, and why psychedelic therapy must not be reduced to a patented, "script and go" biomedical model. Their conversation also examines ACT, trauma, attachment, group experience, spiritual community, and the importance of honoring each person's unique path rather than forcing transformation into averages, labels, or protocols. Steven C. Hayes, Ph.D., is a Nevada Foundatio

  • Psychedelic Preparation: Why Safety Starts in the Body - Dave M. Rabin, M.D., Ph.D.

    Psychedelic Preparation: Why Safety Starts in the Body - Dave M. Rabin, M.D., Ph.D.

    29/06/2026 Duration: 38min

    In this conversation, Paul F. Austin speaks with Dr. Dave Rabin, neuroscientist, board-certified psychiatrist, and co-founder of Apollo Neuroscience, about one of the most important questions in psychedelic work: why do some journeys become overwhelming, destabilizing, or difficult to integrate? Find full show notes and links here: https://thethirdwave.co/podcast/episode-362/?ref=278  Dave explains why safety is not just a matter of set, setting, or a strong screening form. It is a physiological state in the nervous system. Together, Paul and Dave explore how fear, trauma, and dysregulation can shape a person's ability to receive and process a psychedelic experience, and why preparation must include a deeper understanding of the body. The conversation also covers pre-session nervous system assessment, vagus nerve activity, HRV, haptic vibration, breathwork, therapeutic touch, consent, and the role of tools like Apollo Neuro in helping clients feel safe enough to surrender, process, and integrate. Dr. David Ra

  • Be the Work: From Human Doing to Human Being - Stefanie Kleine, Ph.D.

    Be the Work: From Human Doing to Human Being - Stefanie Kleine, Ph.D.

    22/06/2026 Duration: 55min

    In this episode of The Psychedelic Podcast, Paul F. Austin sits down with Dr. Stefanie Kleine, psychospiritual coach, author of BE THE WORK, and co-founder of The Sacred House of Eden, to explore the hidden wound that often drives achievement and why lasting transformation happens on the level of being rather than doing. Find full show notes and links here: https://thethirdwave.co/podcast/episode-361/?ref=278  Drawing on more than two decades of experience coaching executives, founders, athletes, physicians, and other high performers, Stefanie shares how her first psychedelic experience revealed the pattern beneath a lifetime of accomplishment and opened a path toward deeper self-acceptance. She explains her framework of grasping versus generative desire, the Be-Do-Have inversion, and why many personal growth and wellness practices can unintentionally reinforce the same striving they aim to heal. The conversation also explores psychedelic integration, Internal Family Systems-informed coaching, conscious leade

  • Psilocybin Mushrooms: Strains, Potency, and Experience - Paul F. Austin

    Psilocybin Mushrooms: Strains, Potency, and Experience - Paul F. Austin

    15/06/2026 Duration: 31min

    In this solo episode of The Psychedelic Podcast, Paul F. Austin explores one of the most common questions in the psychedelic space: which psilocybin mushroom strain is actually best? Find full show notes and links here: https://thethirdwave.co/podcast/episode-360/?ref=278  Moving beyond the search for the "strongest" mushroom, Paul breaks down the factors that truly shape a meaningful experience, including strain selection, potency, preparation methods, storage practices, individual sensitivity, and the critical role of context. Drawing on years of experience through Third Wave and the Psychedelic Coaching Institute, Paul compares popular strains such as Golden Teacher, Penis Envy, Ghost, Enigma, and Psilocybe natalensis. He also explains why preparation methods like lemon tekking matter, how to think about microdosing versus macrodosing, and why integration remains one of the most important variables in long-term outcomes. Paul F. Austin is an entrepreneur, educator, and pioneer in the psychedelic field. He

  • Choosing the Right Microdose: Psilocybin, LSD, Huachuma  More - Paul F. Austin

    Choosing the Right Microdose: Psilocybin, LSD, Huachuma & More - Paul F. Austin

    08/06/2026 Duration: 46min

    In this special solo episode, adapted from a recent live training, Paul F. Austin explores one of the most important and often overlooked realities of microdosing: different substances create different outcomes. Find full show notes and links here: https://thethirdwave.co/podcast/episode-359/?ref=278  Drawing on more than a decade of experience in psychedelic education and coaching, Paul compares psilocybin, LSD, huachuma (San Pedro), ketamine, and iboga through the lens of client goals, nervous system regulation, emotional processing, cognitive performance, and contraindications. Paul explains why generic microdosing protocols often fall short, how practitioners can better match substances to individual needs, and why context, preparation, and integration matter far more than any single medicine. He also shares why huachuma has become the foundation of the Psychedelic Coaching Institute's microdosing methodology and offers guidance for practitioners looking to support clients with greater precision and care.

page 1 from 19